Caitlyn Dickinson
Pfizer (United States)(US)
Publications by Year
Research Areas
Microscopic Colitis, T-cell and B-cell Immunology, Tuberculosis Research and Epidemiology, Inflammatory Bowel Disease, Antibiotic Resistance in Bacteria
Most-Cited Works
- → Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition(2016)191 cited
- → Activity-Based Metabolomic Profiling of Enzymatic Function: Identification of Rv1248c as a Mycobacterial 2-Hydroxy-3-oxoadipate Synthase(2010)106 cited
- → Children's Safety Initiative: A National Assessment of Pediatric Educational Needs among Emergency Medical Services Providers(2014)73 cited
- → Identification of a Chemical That Inhibits the Mycobacterial UvrABC Complex in Nucleotide Excision Repair(2011)38 cited
- → The Role of Fibroblasts in Self-Assembled Skeletal Muscle(2011)36 cited
- → Proteomic Differences in Colonic Epithelial Cells in Ulcerative Colitis Have an Epigenetic Basis(2024)3 cited
- → Su1140: PROTEOMIC DIFFERENCES IN COLONIC EPITHELIAL CELLS IN ULCERATIVE COLITIS HAVE AN EPIGENETIC BASIS(2022)
- → Ligand non-competitive GITR antibody prevents formation of the obligatory signal-triggering GITRL: GITR stoichiometry(2025)